Pfeil, J., Borrmann, S., & Tozan, Y. (2014). Dihydroartemisinin-piperaquine vs. artemether-lumefantrine for first-line treatment of uncomplicated malaria in African children: A cost-effectiveness analysis. PLOS ONE, 9(4), . https://doi.org/10.1371/journal.pone.0095681
Chicago Style (17th ed.) CitationPfeil, Johannes, Steffen Borrmann, and Yeşim Tozan. "Dihydroartemisinin-piperaquine Vs. Artemether-lumefantrine for First-line Treatment of Uncomplicated Malaria in African Children: A Cost-effectiveness Analysis." PLOS ONE 9, no. 4 (2014). https://doi.org/10.1371/journal.pone.0095681.
MLA (9th ed.) CitationPfeil, Johannes, et al. "Dihydroartemisinin-piperaquine Vs. Artemether-lumefantrine for First-line Treatment of Uncomplicated Malaria in African Children: A Cost-effectiveness Analysis." PLOS ONE, vol. 9, no. 4, 2014, https://doi.org/10.1371/journal.pone.0095681.